IIT Roorkee discovers potential cure for Chikungunya-All you need to know
IIT Roorkee researchers have discovered Efavirenz as a potential drug for Chikungunya treatment. It effectively reduces virus levels in cell cultures and infected mice, and also affects a related virus. Clinical trials can explore its use, potentially reducing time and costs for developing antiviral drugs. However, common side effects and more studies are needed for evaluation.